Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
Haematologica
|
February 9, 2019
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Marie Robin, Liesbeth C de Wreede, Christine Wolschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2020
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR
Giancarlo Fatobene, Vanderson Rocha, Andrew St Martin, et al.
Prostate Cancer and Prostatic Diseases
|
May 2, 2021
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control
Marieke J van Son, Max Peters, Deepika Reddy, et al.
Blood Advances
|
February 7, 2019
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL
Peter Dreger, Anna Sureda, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 9, 2019
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Donal McLornan, Richard Szydlo, Linda Koster, et al.
Bone Marrow Transplantation
|
March 27, 2020
Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative
Chloe Anthias, Jane Apperley, Adrian Bloor, et al.
Blood
|
April 21, 2024
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
Juan Montoro, Dirk-Jan Eikema, Joe Tuffnell, et al.
Haematologica
|
November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Bone Marrow Transplantation
|
March 16, 2024
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Koster, et al.
Nucleic Acids Research
|
November 28, 2007
Priorities for nucleotide trace, sequence and annotation data capture at the Ensembl Trace Archive and the EMBL Nucleotide Sequence Database
Guy Cochrane, Ruth Akhtar, Philippe Aldebert, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
Haematologica
|
February 9, 2019
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Marie Robin, Liesbeth C de Wreede, Christine Wolschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2020
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR
Giancarlo Fatobene, Vanderson Rocha, Andrew St Martin, et al.
Prostate Cancer and Prostatic Diseases
|
May 2, 2021
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control
Marieke J van Son, Max Peters, Deepika Reddy, et al.
Blood Advances
|
February 7, 2019
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL
Peter Dreger, Anna Sureda, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 9, 2019
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Donal McLornan, Richard Szydlo, Linda Koster, et al.
Bone Marrow Transplantation
|
March 27, 2020
Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative
Chloe Anthias, Jane Apperley, Adrian Bloor, et al.
Blood
|
April 21, 2024
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
Juan Montoro, Dirk-Jan Eikema, Joe Tuffnell, et al.
Haematologica
|
November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Bone Marrow Transplantation
|
March 16, 2024
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Koster, et al.
Nucleic Acids Research
|
November 28, 2007
Priorities for nucleotide trace, sequence and annotation data capture at the Ensembl Trace Archive and the EMBL Nucleotide Sequence Database
Guy Cochrane, Ruth Akhtar, Philippe Aldebert, et al.
Page
of 15